The company has proposed a final dividend of Rs 50 per equity share (with an ex-dividend date of November 21, 2023), representing an astounding 500 per cent final dividend payout.

Comparing to the same quarter last year, the net profit for the first quarter of FY24 soared 55.11 per cent to Rs 25.33 crore.

The company boasts a return on equity exceeding 20 per cent, alongside an impressive earnings per share (EPS) of Rs 50.

The company also recorded an 82 per cent growth in net profit for the June quarter.

The consolidated net profit for the June quarter recorded robust growth of more than 50 per cent.

The company's net profit climbed more than 78 per cent year-on-year!

Shares have seen significant buying interest and have soared around 75 per cent in past six months!

Hence, if you are an investor who wishes to receive a bonus share in the pharmaceutical company

The stock has rewarded its shareholder with handsome capital appreciation and testimony of this is the fact that it has jumped 155.4 per cent in the last one year.